Evidence map›Paper›PMID 40671729›Full record

ArticleJournal of diabetes and metabolic disorders2025

Nobiletin can play a role in improving inflammation by inhibiting the NF-kB and MAPK pathways in muscle cells.

Mohammad Tahmasbi, Amin Karimpour, Mojtaba Rashidi, Mohammad Zangooei, Azam Khedri, Ghodratollah Panahi

Abstract read
In one paragraph

Article in Journal of diabetes and metabolic disorders, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mohammad TahmasbiDepartment of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Amin KarimpourDepartment of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mojtaba RashidiDepartment of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Mohammad ZangooeiDepartment of Biochemistry, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran.
Azam KhedriDepartment of Clinical Biochemistry, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Ghodratollah PanahiDepartment of Clinical Biochemistry, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.ORCID 0000-0001-8338-4633

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Insulin resistance and inflammation plays a major role in the pathogenesis of metabolic diseases such as diabetes and metabolic syndrome. Increased circulating fatty acids and inflammatory cytokines are among the most important factors that induce inflammation and subsequent insulin resistance. Studies indicate that fatty acids, especially palmitate, play a role in inducing inflammation and increasing inflammatory cytokines such as TNF-ɑ and IL-6 and stimulating the NF-kB and MAPK (especially JNK) signaling pathways. Nobiletin (Nob) as a natural polyphenol has anti-diabetic and anti-inflammatory effects. However, its mechanism in muscle cells is unclear, which was addressed in this study. Materials and methods: The increase in inflammatory cytokines TNF-ɑ and IL-6 caused by palmitate was evaluated by Real-time PCR. The expression of NF-kB and JNK proteins caused by palmitate was also measured by Western blotting. The effect of Nob on cytokines and inflammatory pathways in palmitate-treated C2C12 cells was assessed by Real-time PCR and Western blotting. Intracellular ROS levels were also measured using the DCFH-DA probe. Results: Palmitate significantly increased the expression and secretion of inflammatory genes TNF-α, IL-6, and IL-1β and the phosphorylation of NF-KB and JNK in muscle cells, and in contrast, nobiletin at a concentration of 100 µM significantly decreased the expression of inflammatory genes TNF-α, IL-6, and IL-1β and the phosphorylation of NF-KB and JNK in muscle cells treated with palmitate. Intracellular ROS levels were increased by palmitate, which was reduced by nobiletin treatment, but this decrease was not statistically significant. Conclusion: This study showed that the beneficial anti-inflammatory effects of nobiletin in muscle cells are accompanied by suppression of ROS production and reduction of MAPK activity (especially JNK) and inhibition of the NF-kB signaling pathway. We introduce nobiletin as a potential anti-inflammatory and anti-diabetic natural compound so that its therapeutic effects can be further studied.

Indexed as

DiabetesInflammationInsulin resistanceNobiletinPalmitatePlant polyphenol

Identifiers

PMID40671729
PMCPMC12259501

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.